Six months after GSK stopped making a popular inhaler, pediatric patients with asthma still struggle to find alternative medications while urgent cares and hospitals contend with a rise in asthma-related pediatric visits, NPR reported July 22.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
